Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland.
Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Pediatr Diabetes. 2022 Nov;23(7):944-955. doi: 10.1111/pedi.13379. Epub 2022 Jul 4.
There are several observations that the onset of coronavirus 19 (COVID-19) pandemic was associated with an increase in the incidence of diabetic ketoacidosis (DKA). However, due to heterogeneity in study designs and country-specific healthcare policies, more national-level evidence is needed to provide generalizable conclusions.
To compare the rate of DKA in Polish children diagnosed with type 1 diabetes (T1D) between the first year of COVID-19 pandemic (15 March 2020 to 15 March 2021) and the preceding year (15 March 2019 to 15 March 2020).
Reference centers in 13 regions (covering ~88% of Polish children) retrospectively reported all new-onset T1D cases in children from assessed periods, including DKA status at admission, administered procedures and outcomes. Secondly, we collected regions' demographic characteristics and the daily-reported number of COVID-19-related deaths in each region.
We recorded 3062 cases of new-onset T1D (53.3% boys, mean age 9.5 ± 4.3 years old) of which 1347 (44%) had DKA. Comparing pre- and post-COVID-19 period, we observed a significant increase in the rate of DKA (37.5%-49.4%, p < .0001). The fraction of moderate (+5.4%) and severe (+3.4%) DKA cases increased significantly (p = .0089), and more episodes required assisted ventilation (+2.1%, p = .0337). Two episodes of DKA during 2020/2021 period were fatal. By region, change in DKA frequency correlated with initial COVID-19 death toll (March/April 2020) (R = .6, p = .0287) and change in T1D incidence (R = .7, p = .0080).
The clinical picture of new-onset children T1D in Poland deteriorated over a 2-year period. The observed increase in the frequency of DKA and its severity were significantly associated with the overlapping timing of the COVID-19 epidemic.
有几项观察结果表明,2019 年冠状病毒病(COVID-19)大流行的开始与糖尿病酮症酸中毒(DKA)发病率的增加有关。然而,由于研究设计和特定国家医疗政策的异质性,需要更多的国家级证据来提供可推广的结论。
比较波兰儿童在 COVID-19 大流行的第一年(2020 年 3 月 15 日至 2021 年 3 月 15 日)和前一年(2019 年 3 月 15 日至 2020 年 3 月 15 日)确诊为 1 型糖尿病(T1D)的儿童中 DKA 的发生率。
13 个地区的参考中心(覆盖波兰儿童的~88%)回顾性报告了评估期间所有新确诊的 T1D 病例,包括入院时的 DKA 状态、实施的程序和结果。其次,我们收集了各地区的人口统计学特征和每个地区每天报告的 COVID-19 相关死亡人数。
我们记录了 3062 例新确诊的 T1D(53.3%为男孩,平均年龄 9.5±4.3 岁),其中 1347 例(44%)患有 DKA。与 COVID-19 前相比,我们观察到 DKA 发生率显著增加(37.5%-49.4%,p<.0001)。中度(+5.4%)和重度(+3.4%)DKA 病例的比例显著增加(p=0.0089),需要辅助通气的发作次数也增加(+2.1%,p=0.0337)。2020/2021 期间有两例 DKA 死亡。按地区划分,DKA 频率的变化与初始 COVID-19 死亡人数(2020 年 3 月/4 月)相关(R=0.6,p=0.0287),与 T1D 发病率的变化相关(R=0.7,p=0.0080)。
波兰新诊断的儿童 1 型糖尿病的临床情况在 2 年内恶化。观察到的 DKA 频率增加及其严重程度与 COVID-19 流行的重叠时间显著相关。